Regulatory Blog

The Regulatory News you Need to Know,Share & Grow

Aug 112 min read

USFDA Guidance: Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases

Last Thursday (08 August 2024) the U.S. Food and Drug Administration (FDA) released final guidance aimed at " Optimizing the Dosage of...

Feb 1, 20231 min read

ICH (USFDA) Guidance: Bioequivalence for Immediate-Release Solid Oral Dosage Forms

The USFDA released draft guidance for the industry on January 31, 2023, “M13A Bioequivalence for Immediate-Release Solid Oral Dosage...